CHL1 | Cell adhesion molecule L1-like | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL5RA | Interleukin 5 receptor, alpha | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TRNT1 | TRNA nucleotidyl transferase, CCA-adding, 1 | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
CRBN | Cereblon | Disease related genes FDA approved drug targets
| | | | | Expressed in all |
LRRN1 | Leucine rich repeat neuronal 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
ITPR1 | Inositol 1,4,5-trisphosphate receptor, type 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
BHLHE40 | Basic helix-loop-helix family, member e40 | Transcription factors
| | | | | Expressed in all |
ARL8B | ADP-ribosylation factor-like 8B | Predicted secreted proteins
| | | | | Expressed in all |
LMCD1 | LIM and cysteine-rich domains 1 | | | | | | Tissue enhanced |
CAV3 | Caveolin 3 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
RAD18 | RAD18 homolog (S. cerevisiae) | Plasma proteins
| | | | | Mixed |
SRGAP3 | SLIT-ROBO Rho GTPase activating protein 3 | Cancer-related genes Disease related genes
| | | | | Tissue enhanced |
THUMPD3 | THUMP domain containing 3 | | | | | | Expressed in all |
SETD5 | SET domain containing 5 | Disease related genes
| | | | | Expressed in all |
MTMR14 | Myotubularin related protein 14 | Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
BRPF1 | Bromodomain and PHD finger containing, 1 | Plasma proteins
| | | | | Expressed in all |
OGG1 | 8-oxoguanine DNA glycosylase | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
TADA3 | Transcriptional adaptor 3 | | | | | | Expressed in all |
EMC3 | ER membrane protein complex subunit 3 | Predicted membrane proteins
| | | | | Expressed in all |
FANCD2 | Fanconi anemia, complementation group D2 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Mixed |
VHL | Von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes
| | | | | Expressed in all |
GHRL | Ghrelin/obestatin prepropeptide | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC6A1 | Solute carrier family 6 (neurotransmitter transporter), member 1 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
HRH1 | Histamine receptor H1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
ATG7 | Autophagy related 7 | | | | | | Expressed in all |
TSEN2 | TSEN2 tRNA splicing endonuclease subunit | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
MKRN2 | Makorin ring finger protein 2 | | | | | | Expressed in all |
TMEM40 | Transmembrane protein 40 | Predicted membrane proteins
| | | | | Group enriched |
RPL32 | Ribosomal protein L32 | Plasma proteins Ribosomal proteins
| | | | | Expressed in all |
NUP210 | Nucleoporin 210kDa | Predicted membrane proteins
| | | | | Expressed in all |
FBLN2 | Fibulin 2 | Plasma proteins Predicted secreted proteins
| | | | | Mixed |
WNT7A | Wingless-type MMTV integration site family, member 7A | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
XPC | Xeroderma pigmentosum, complementation group C | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
SLC6A6 | Solute carrier family 6 (neurotransmitter transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
CCDC174 | Coiled-coil domain containing 174 | | | | | | Expressed in all |
C3orf20 | Chromosome 3 open reading frame 20 | | | | | | Tissue enriched |
NR2C2 | Nuclear receptor subfamily 2, group C, member 2 | Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
MRPS25 | Mitochondrial ribosomal protein S25 | Mitochondrial proteins Ribosomal proteins
| | | | | Expressed in all |
ZFYVE20 | Zinc finger, FYVE domain containing 20 | | | | | | Expressed in all |
CAPN7 | Calpain 7 | Enzymes
| | | | | Expressed in all |
EAF1 | ELL associated factor 1 | | | | | | Expressed in all |
DPH3 | Diphthamide biosynthesis 3 | | | | | | Expressed in all |
DAZL | Deleted in azoospermia-like | | | | | | Tissue enriched |
TBC1D5 | TBC1 domain family, member 5 | Predicted membrane proteins
| | | | | Expressed in all |
KAT2B | K(lysine) acetyltransferase 2B | Cancer-related genes Enzymes
| | | | | Expressed in all |
SGOL1 | Shugoshin-like 1 (S. pombe) | | | | | | Mixed |
RARB | Retinoic acid receptor, beta | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Mixed |
TOP2B | Topoisomerase (DNA) II beta 180kDa | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
NGLY1 | N-glycanase 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |